Wednesday 19 September 2018 ,
Wednesday 19 September 2018 ,
Latest News
  • Govt firmly believes in freedom of press: PM
  • ICC launches Myanmar Rohingya crimes probe
  • Suu Kyi's bronze sculpture to be auctioned for underprivileged in Myanmar
  • North Korea agrees to shut down missile test sites
  • Myanmar domestic commissions fail to report credible atrocities against Rohingya: HRW
10 September, 2018 00:00 00 AM

Hypertension drugs could prevent memory loss in lupus patients, study suggests

MedicalXpress
Hypertension drugs could prevent memory loss in lupus patients, study suggests
Exposure to DNRAbs (right) reduces the number of neurons and neuronal connections in the CA1 region of the hippocampus, a brain region important for spatial memory. Memory loss can be prevented in mice by ACE inhibitors such as captopril that block the activation of brain cells called microglia. Credit: Nestor et al., 2018

Researchers from The Feinstein Institute for Medical Research have discovered that the activation of brain cells called microglia likely contributes to the memory loss and other cognitive impairments suffered by many patients with systemic lupus erythematosus (SLE). The study, which will be published September 5 in the Journal of Experimental Medicine, shows that ACE inhibitors—a class of drugs commonly used to treat hypertension—can block this process in mice and might therefore be used to preserve the memory of lupus patients.

SLE is a complex autoimmune disease that arises when the body starts to make antibodies that target its own, healthy cells, often specifically recognizing DNA. Patients can suffer a wide variety of symptoms, but as many as 90% develop neuropsychiatric lupus, which is often characterized by cognitive impairments such as memory loss or confusion.

Betty Diamond and colleagues at The Feinstein Institute for Medical Research in Manhasset, NY, previously found that lupus patients experiencing memory loss often produce antibodies—called DNRAbs—that recognize both DNA and a critical brain protein called the NMDA receptor, NMDAR. Antibodies are usually unable to enter the brain, but, after injury or infection, DNRAbs are thought to gain temporary access to the brain, where they can target neurons expressing NMDAR. This causes the neurons to die or lose the synapses that connect them to neighboring nerve cells, resulting in memory loss or other cognitive defects.

Diamond and colleagues suspected that brain cells called microglia might be responsible for trimming the connections between neurons after exposure to DNRAbs. These cells help clear away the debris of dead and dying neurons and can also remove excessive or unwanted synapses during brain development.

To address the role of microglia in SLE, Diamond and colleagues analyzed mice that produce DNRAbs capable of penetrating the brain and inducing memory loss. The researchers found that microglia are activated when DNRAbs enter the brain and that a protein called C1q attracts microglia to the synapses of neurons targeted by these antibodies. Deleting the C1q protein, or depleting the microglial cells themselves, prevented neurons from losing their synapses after exposure to DNRAbs.

ACE inhibitors such as captopril are a class of drugs used to treat high blood pressure. They are also known to block the activation of microglia. Diamond and colleagues found that captopril treatment protected neurons from DNRAbs and preserved the memory of mice producing these antibodies.

"Our study suggests that ACE inhibitors are a promising class of therapeutics that can easily move into clinical trials aimed at mitigating the cognitive dysfunction associated with neuropsychiatric lupus," Diamond says.

 

Comments

Most Viewed
Digital Edition
More story
From the Editor

From the Editor

Communication between organs and organ  system is vital. It allows the body to adjust the function of each organ according to the needs of the whole…
What are hormones?

What are hormones?

A hormone is a chemical released by one or more cells that affects cells in other parts of the organism. Only a small amount of hormone is required to…
Hormones 101 - what you really need to know

Hormones 101 - what you really need to know

While a great number of women in our culture develop some kind of sexual reproductive organ dysfunction, most are misled about true sexual and reproductive…
Hormonal imbalance

Hormonal imbalance

Hormones are your body’s chemical messengers. Produced in the endocrine glands, these powerful chemicals travel around your bloodstream telling…
New hormonal link suspected in type 2 diabetes

New hormonal link suspected in type 2 diabetes

Two disorders that often occur together -- type 2 diabetes and high blood pressure -- may have a common link in a hormone called aldosterone, researchers…
Deadly infections in kids: What you should know about sepsis

Deadly infections in kids: What you should know about sepsis

ITALO M. BROWN If you try on shoes barefoot, can you get a life-threatening infection? It turns out that this may have already happened, according to…
Signs of depression

Signs of depression

While only a qualified medical or mental health provider can diagnose depression, there are certain warning signs that can help you identify whether you…
Lack of exercise puts one in four people at risk, WHO says

Lack of exercise puts one in four people at risk, WHO says

Alex Therrien Very little progress has been made in reducing levels of inactivity worldwide, experts have warned. A WHO report estimates that more than…
Cancers 'rising around the world'

Cancers 'rising around the world'

Smitha Mundasad There will be 18.1 million new cases of cancer and 9.6 million people will die with the disease this year worldwide, a report predicts.…
Folic acid won't curb dangerous pregnancy complication

Folic acid won't curb dangerous pregnancy complication

High doses of folic acid do not protect pregnant women against a sometimes deadly complication called preeclampsia, a large trial suggests. The finding…
 FDA approves Jivi

FDA approves Jivi

Bayer receives FDA approval for Jivi (antihemophilic factor (recombinant), PEGylated-aucl) for prophylactic treatment of hemophilia A Bayer announced…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting